Today's biggest gainers and decliners in the stock market. 

On this episode of Stock Movers:

- Shopify (SHOP) shares are trading higher in trading today, extending Monday’s gains after Chief Executive Officer Tobi Lutke announced on the social media platform X that the e-commerce firm was “partnering deeply” with Meta Platforms’ Muse artificial intelligence agent.

- Morderna (MRNA) shares are also extending gains for a second day, to hit its highest intraday level since 2023. The biotech previously reported on Monday that it will present data on its personalized cancer vaccine in October. 

- On (ONON) expects sales growth in the high teens over the next few years as the Swiss sneaker brand moves into sports including golf and football to take on the likes of Adidas and Nike. Backed by tennis legend Roger Federer, On has grown rapidly since its 2010 founding, starting with running shoes and expanding into tennis, training and outdoor sports. A 10-year partnership with French superstar Kylian Mbappé breaks new ground for On in football, long dominated by its bigger rivals. The stock rallied as much as 14% in New York, the most intraday since November.

Today's biggest gainers and decliners in the stock market.&nbsp;
On this episode of Stock Movers:
- Shopify (SHOP) shares are trading higher in trading today, extending Monday&rsquo;s gains after Chief Executive Officer Tobi Lutke announced on the social media platform X that the e-commerce firm was &ldquo;partnering deeply&rdquo; with Meta Platforms&rsquo; Muse artificial intelligence agent.
- Morderna (MRNA) shares are also extending gains for a second day, to hit its highest intraday level since 2023. The biotech previously reported on Monday that it will present data on its personalized cancer vaccine in October.&nbsp;
- On (ONON) expects sales growth in the high teens over the next few years as the Swiss sneaker brand moves into sports including golf and football to take on the likes of Adidas and Nike. Backed by tennis legend Roger Federer, On has grown rapidly since its 2010 founding, starting with running shoes and expanding into tennis, training and outdoor sports. A 10-year partnership with French superstar Kylian Mbapp&eacute; breaks new ground for On in football, long dominated by its bigger rivals. The stock rallied as much as 14% in New York, the most intraday since November.

Listen for Short conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for Short conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Listen for short conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for short conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Shopify Gains, Moderna Climbs, On Rallies 

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6b1da345-1cb1-4897-b65e-b4cd013bcfd0/transcript

Today's biggest winners and losers in the stock market, a look at the notable movers: 
On this episode of Stock Movers:

- Apple (AAPL) is developing a screenless health and fitness tracker similar to Whoop Inc.'s wrist-worn device as part of an effort to rethink its smartwatch lineup and add new wearable technologies. The company has been exploring the category for several months and is now developing prototypes, with the effort having support from top executives, including Apple Executive Chairman Tim Cook and services chief Eddy Cue. The project remains in a preliminary phase, and if Apple proceeds with a release, the device likely won't debut before 2028, featuring a thin fabric band with a sensor-equipped computing module and distinguishing it from the Apple Watch.

- Sandisk (SNDK) shares are up 7.4% on Tuesday, after Rosenblatt Securities started coverage on the computer hardware and storage company with a buy rating and $2,400 price target, citing AI tailwinds to growth. The stock is the day’s biggest percentage gainer among S&P 500 Index components.

- Lennar (LEN) shares rise as much as 6.2%, the most intraday since June 24, after Berkshire Hathaway increased its stake in the homebuilder over three trading days.

Today's biggest winners and losers in the stock market, a look at the notable movers: On this episode of Stock Movers: - Apple (AAPL) is developing a screenless health and fitness tracker similar to Whoop Inc.'s wrist-worn device as part of an effort to rethink its smartwatch lineup and add new wearable technologies. The company has been exploring the category for several months and is now developing prototypes, with the effort having support from top executives, including Apple Executive Chairman Tim Cook and services chief Eddy Cue. The project remains in a preliminary phase, and if Apple proceeds with a release, the device likely won't debut before 2028, featuring a thin fabric band with a sensor-equipped computing module and distinguishing it from the Apple Watch. - Sandisk (SNDK) shares are up 7.4% on Tuesday, after Rosenblatt Securities started coverage on the computer hardware and storage company with a buy rating and $2,400 price target, citing AI tailwinds to growth. The stock is the day&rsquo;s biggest percentage gainer among S&amp;P 500 Index components. - Lennar (LEN) shares rise as much as 6.2%, the most intraday since June 24, after Berkshire Hathaway increased its stake in the homebuilder over three trading days.

Apple Debuts Health Tracker, Sandisk Jumps, Lennar Gains

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/7fba53e3-702c-4463-9dbc-b4cd015f68d3/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Viking Therapeutics (VKTX) shares surged after its dual-action obesity shot helped patients lose weight and keep it off, even after they cut their dosing schedule in a small, exploratory study. 

- On Holding (ONON) shares jump after the Swiss sneaker maker provided its three-year financial plan ahead of its Investor Day in Zurich, Switzerland. Management also declared a buyback plan of up to $1 billion of its Class A shares through the end of 2029. It reaffirmed its annual outlook and projected 3Q sales growth up ~17% in constant currency (CC) vs mid-to-high-teens prior.

- Quest Diagnostics (DGX) shares fall most intraday since 2022, after the Centers for Medicare & Medicaid Services (CMS) released new preliminary medicare payment rates for lab services.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Viking Therapeutics (VKTX) shares surged after its dual-action obesity shot helped patients lose weight and keep it off, even after they cut their dosing schedule in a small, exploratory study.&nbsp;
- On Holding (ONON) shares jump after the Swiss sneaker maker provided its three-year financial plan ahead of its Investor Day in Zurich, Switzerland. Management also declared a buyback plan of up to $1 billion of its Class A shares through the end of 2029. It reaffirmed its annual outlook and projected 3Q sales growth up ~17% in constant currency (CC) vs mid-to-high-teens prior.
- Quest Diagnostics (DGX) shares fall most intraday since 2022, after the Centers for Medicare &amp; Medicaid Services (CMS) released new preliminary medicare payment rates for lab services.

Viking Soars; On Holding Climbs; Quest Diagnostics Drops

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/576398f0-5d2e-4d8b-aff0-b4cd00eefedc/transcript

On this episode of Stock Movers:

- Alibaba (BABA) shares are higher this morning after the company rolled out what it calls China’s most powerful AI chip and announced plans to expand data center capacity in the coming years.

- ON Holdings (ONON) is getting a boost as it expects sales growth in the high teens over the next few years as it moves into sports including golf and football.

- Viking Therapeutics (VKTX) shares surged after the biotech released data from its VK2735-102 maintenance study showing VK2735, its experimental obesity drug, maintained up to 97% of weight loss versus 61% for placebo when subjects switched to every-other-week dosing. Leerink analysts said the “stellar” data strengthens the drug’s competitive profile.

On this episode of Stock Movers:
- Alibaba (BABA) shares are higher this morning after the company rolled out what it calls China&rsquo;s most powerful AI chip and announced plans to expand data center capacity in the coming years.
- ON Holdings (ONON) is getting a boost as it expects sales growth in the high teens over the next few years as it moves into sports including golf and football.
- Viking Therapeutics (VKTX) shares surged after the biotech released data from its VK2735-102 maintenance study showing VK2735, its experimental obesity drug, maintained up to 97% of weight loss versus 61% for placebo when subjects switched to every-other-week dosing. Leerink analysts said the &ldquo;stellar&rdquo; data strengthens the drug&rsquo;s competitive profile.

Alibaba and ON Rise; Viking Therapeutics Surges

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/76c28351-8116-4692-9ed3-b4cd00d82420/transcript

Shopify Gains, Moderna Climbs, On Rallies

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips